ACSS2 upregulation enhances neuronal resilience to aging and tau-associated neurodegeneration
Naemeh Pourshafie, Desi C. AlexanderiD, Hong Wei XuiD, Kechun YangiD, Greg DonahueiD, Xue LeiiD, Shuo Zhang, Oksana ShcherbakovaiD, Connor HoganiD, Michael Gilbert, Kevt’her Hoxha, Lesley S. ChaboubiD, Virginia M.‐Y. LeeiD, Peter D. AdamsiD, John A. DaniiD, Nancy M. BoniniiD, Shelley L. BergeriD
Abstract
Epigenetic mechanisms, including histone acetylation, are pivotal for learning and memory, with a role in neuronal function in Alzheimers disease and Related Dementia (ADRD). Acetyl-CoA synthetase 2 (ACSS2), an enzyme that generates acetyl-CoA, is central to histone acetylation and gene regulation, particularly in neurons, due to their unique metabolic demands and postmitotic state. ACSS2 can be recruited to the nucleus and chromatin, locally supplying acetyl-CoA to directly fuel histone acetyltransferase enzymes and key neuronal gene expression. This regulatory mechanism may be a promising target for therapeutic intervention in neurodegenerative diseases. Previously we showed that systemic ACSS2 deletion in mice, although largely normal in physiology, is greatly impaired in memory. Here we investigated whether increasing ACSS2 levels could protect neurons against disease and age-associated cognitive decline. Given the role of tau in ADRD, we used primary hippocampal neurons that mimic the sporadic development of tau pathology and the P301S transgenic mouse model for tau-induced memory decline. Our results show that ACSS2 upregulation mitigates tau-induced transcriptional alterations, enhances neuronal resilience against tau pathology, improves long-term potentiation, and ameliorates memory deficits. Expanding upon these findings, we reveal that increasing histone acetylation through ACSS2 upregulation improves age-associated memory decline. These findings indicate that increasing ACSS2 is highly effective in countering age- and tau-induced transcriptome changes, preserving elevated levels of synaptic genes, and safeguarding synaptic integrity. We thus highlight ACSS2 as a key player in the epigenetic regulation of cognitive aging and ADRD, providing a foundation for targeted therapeutics to enhance brain resilience and function. SummaryACSS2 upregulation protects neurons from disease and age-related decline by enhancing synaptic and longevity gene expression.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 18.05
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ACSS2 contributes to transcriptional regulation in Cajal-Retzius cells in a mouse model of Alzheimer's disease
Gabor Egervári, Desi C. Alexander, … Shelley L. Berger·bioRxiv·Apr 8, 2024
- Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer's disease-related phenotypes
Yun Lei, Yuting Chen, … Xin‐Yun Lu·Molecular PsychiatryPeer-reviewed·Apr 4, 2026
- Altered NPTX2 dynamics associated with impaired cognitive aging
Rebecca P. Haberman, Ana Delgado, … Audrey Branch·bioRxiv·Sep 15, 2025
- Targeting acetyl-CoA metabolism attenuates the formation of fear memories through reduced activity-dependent histone acetylation
Desi C. Alexander, Tanya S. Corman, … Shelley L. Berger·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 3, 2022
- Evidence that an HDAC2-targeted ASO persistently upregulates cortical acetylcholine and dopamine signaling via a CREB | Gs positive feedback loop
Teresa Hinkle Sanders·bioRxiv·Sep 24, 2020
- The astrocytic secretome increases adult hippocampal neurogenesis and spatial memory in health and disease
Marta Vilademunt, Charline Carron, … Nicolas Toni·bioRxiv·Sep 29, 2026